Dublin, Aug. 10, 2017 (GLOBE NEWSWIRE) -- The "mHealth and Home Monitoring - 8th Edition" report has been added to Research and Markets' offering.

This strategic research report provides you with unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of home monitoring devices on the global market with integrated cellular connectivity was 4.9 million at the end of 2016 and is forecasted to grow at a CAGR of 38.7 percent in the next five years to reach 25.2 million in 2021. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 280 page in-depth report now in its eighth edition.

The world's leading M2M/IoT market research provider, released new findings about the mHealth market. The number of remotely monitored patients grew by 44 percent to 7.1 million in 2016 as the market entered a growth phase fuelled by rising market acceptance in several key verticals. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Connected medical devices used for various forms of personal health tracking are not included in this figure.

The author estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 47.9 percent to reach 50.2 million by 2021. The two main applications are monitoring of patients with sleep therapy devices and monitoring of patients with implantable cardiac rhythm management (CRM) devices. These two verticals accounted for 80 percent of all connected home medical monitoring systems in 2016. The number of remotely monitored sleep therapy patients grew by 70 percent in 2016, mainly driven by Resmed that has made connected healthcare a cornerstone of its strategy says Anders Frick, Senior Analyst at Berg Insight.

Other leading vendors in this segment are Philips Respironics and SRETT. The CRM market is led by companies such as Medtronic, Boston Scientific and St. Jude Medical (now Abbott) that included connectivity in CRM solutions more than a decade ago. Telehealth is the third largest segment with 0.50 million connections at the end of the year. Leading telehealth hub vendors include Tunstall Healthcare, Honeywell, Cardiocom, Philips and Qualcomm Life. All other device categories - including ECG, glucose level, medication adherence and others - stood for less than one million connections together. Cellular connectivity has already replaced PSTN and LAN as the de-facto standard communication technology for most types of connected home medical monitoring devices. The number of mHealth devices with integrated cellular connectivity increased from 3.0 million in 2015 to 4.9 million in 2016.

The use of BYOD connectivity will increase the most during the next five years, with a forecasted CAGR of 109 percent. BYOD involves low costs, but cannot be used to reliably connect every patient. The technology will be most useful for patient-centric engagement programs in therapeutic areas such as diabetes and asthma that have younger patient demographics compared to many other chronic diseases. In fact, many of these patients will prefer to use their own smartphone as the interface instead of carrying around a dedicated device for remote monitoring.

Key Topics Covered:

Executive summary

1. The challenge from welfare diseases
1.1. Introduction
1.1.1. The ageing world population
1.1.2. Metabolic syndrome and lifestyle related diseases
1.2. Common chronic diseases
1.2.1. Cardiac arrhythmia
1.2.2. Ischemic diseases
1.2.3. Hypertension
1.2.4. Sleep apnea
1.2.5. Chronic respiratory diseases
1.2.6. Diabetes
1.2.7. Hyperlipidemia
1.3. Healthcare providers and reimbursement systems
1.3.1. Healthcare in Asia-Pacific
1.3.2. Healthcare in Europe
1.3.3. Healthcare in North America
1.4. Regulatory environment
1.4.1. Regulatory environment in Europe
1.4.2. Regulatory environment in the US
1.4.3. Regulatory environment in other major markets
1.4.4. International standardisation

2. mHealth platforms
2.1. Overview of the mHealth market
2.1.1. mHealth market segments
2.1.2. Connectivity options for medical devices
2.1.3. The mHealth technology value chain
2.2. mHealth connectivity solutions
2.2.1. Apple HealthKit
2.2.2. Ericsson
2.2.3. Google Fit
2.2.4. iHealth (eDevice)
2.2.5. KORE
2.2.6. MedM
2.2.7. Microsoft HealthVault
2.2.8. Orange Healthcare
2.2.9. PTC
2.2.10. Qualcomm Life
2.2.11. Telenor Connexion
2.2.12. Vodafone
2.3. mHealth care delivery platforms
2.3.1. AT&T
2.3.2. BePatient
2.3.3. Domicalis
2.3.4. Exco InTouch
2.3.5. Get Real Health
2.3.6. HealthyCircles (Qualcomm Life)
2.3.7. Medixine
2.3.8. OpenTeleHealth
2.3.9. S3. Group
2.3.10. Tactio Health
2.3.11. Verklizan

3. Physiological monitoring solution providers
3.1. Medical devices and remote monitoring
3.1.1. Medical device revenues by market segment
3.1.2. Overview of the remote patient monitoring market
3.2. Cardiac rhythm management
3.2.1. Overview of the CRM device market
3.2.2. Use cases for CRM monitoring
3.2.3. Remote monitoring solution providers
3.2.4. Biotronik
3.2.5. Boston Scientific
3.2.6. Medtronic
3.2.7. LivaNova
3.2.8. St. Jude Medical
3.3. Remote ECG monitoring
3.3.1. Overview of the remote ECG monitoring device market
3.3.2. Use cases for remote ECG monitoring
3.3.3. Remote monitoring solution providers
3.3.4. Aerotel Medical Systems
3.3.5. AliveCor
3.3.6. BioTelemetry
3.3.7. CardioComm Solutions
3.3.8. LifeWatch
3.3.9. ScottCare
3.3.10. TZ Medical
3.3.11. Zenicor
3.3.12. Preventice Solutions
3.3.13. KHS Medical (LevMed)
3.4. Blood pressure monitoring
3.4.1. Overview of the blood pressure monitoring device market
3.4.2. Use cases for blood pressure monitoring
3.4.3. Remote monitoring solution providers
3.4.4. Omron Healthcare
3.4.5. A&D Medical
3.4.6. Microlife
3.4.7. Rossmax
3.4.8. Sotera Wireless
3.5. Coagulation monitoring
3.5.1. Overview of the coagulation monitoring device market
3.5.2. Use cases for blood coagulation monitoring
3.5.3. Remote monitoring solution providers
3.5.4. Accriva Diagnostics
3.5.5. Alere
3.5.6. CoaguSense
3.5.7. Helena Laboratories
3.5.8. iLine Microsystems
3.5.9. Siemens Healthineers
3.5.10. Roche Diagnostics
3.6. Sleep therapy monitoring
3.6.1. Overview of the sleep therapy device market
3.6.2. Use cases for sleep therapy monitoring
3.6.3. Remote monitoring solution providers
3.6.4. Fisher & Paykel Healthcare
3.6.5. Philips Respironics
3.6.6. ResMed
3.6.7. SRETT
3.6.8. SomnoMed
3.6.9. Lwenstein Medical Technology (Weinmann)
3.6.10. Drive DeVilbiss Healthcare
3.7. Home sleep diagnostics
3.7.1. Overview of the home sleep diagnostics market
3.7.2. Use cases for home sleep diagnostics
3.7.3. Remote monitoring solution providers
3.7.4. Cadwell Laboratories
3.7.5. CareFusion (BD Medical)
3.7.6. Compumedics
3.7.7. Infoscan
3.7.8. Natus Medical
3.7.9. NovaSom
3.7.10. SleepMed
3.7.11. CleveMed
3.8. Blood oxygen monitoring
3.8.1. Overview of the blood oxygen monitoring device market
3.8.2. Use cases for blood oxygen monitoring
3.8.3. Remote monitoring solution providers
3.8.4. ChoiceMMed
3.8.5. Masimo
3.8.6. Nonin Medical
3.9. Air flow monitoring
3.9.1. Overview of the air flow monitoring device market
3.9.2. Use cases for air flow monitoring
3.9.3. Remote monitoring solution providers
3.9.4. Aerocrine (Circassia Pharmaceuticals)
3.9.5. AstraZeneca
3.9.6. Clement Clarke International
3.9.7. Respiri (iSonea)
3.9.8. Medical International Research
3.9.9. Ndd Medizintechnik
3.9.10. nSpire Health
3.9.11. Propeller Health
3.9.12. Sibelmed
3.9.13. Vitalograph
3.10. Glucose level monitoring
3.10.1. Overview of the glucose monitoring device market
3.10.2. Use cases for glucose monitoring
3.10.3. Remote monitoring solution providers
3.10.4. Abbott
3.10.5. Bayer Healthcare
3.10.6. BodyTel
3.10.7. Dexcom
3.10.8. Glooko (Diasend)
3.10.9. Johnson & Johnson
3.10.10. QuiO
3.10.11. Roche Diabetes Care
3.10.12. Telcare
3.10.13. Voluntis
3.10.14. WellDoc
3.11. Other
3.11.1. Implantable medical devices
3.11.2. Home hemodialysis
3.11.3. Telerehabilitation

4. Medication, AED and integrated monitoring solution providers
4.1. Telehealth and multiparameter monitoring solutions
4.1.1. Overview of the telehealth solutions market
4.1.2. Use cases for telehealth solutions
4.1.3. Telehealth solution providers
4.1.4. Aeon Clinical Laboratories (AuthentiDate)
4.1.5. Bosch Healthcare
4.1.6. Care Innovations
4.1.7. H2AD
4.1.8. Honeywell Life Care Solutions
4.1.9. Ideal Life
4.1.10. LindaCare
4.1.11. Medtronic Care Management Services (Cardiocom)
4.1.12. Medvivo
4.1.13. Optum
4.1.14. Philips Hospital to Home
4.1.15. SHL Telemedicine
4.1.16. Telefnica
4.1.17. Tunstall Healthcare Group
4.1.18. Vitaphone
4.2. Medication compliance monitoring
4.2.1. Overview of the medication compliance monitoring market
4.2.2. Use cases for medication compliance monitoring
4.2.3. Compliance monitoring solution providers
4.2.4. Compliance Meds Technologies
4.2.5. DayaMed
4.2.6. Evondos
4.2.7. InRange Systems
4.2.8. Medicpen
4.2.9. Merck
4.2.10. MedSignals
4.2.11. Philips Medido
4.2.12. Proteus Digital Health
4.3. Connected automated external defibrillators
4.3.1. Use cases for defibrillators
4.3.2. Overview of the connected defibrillator market
4.3.3. A.M.I. Italia
4.3.4. AEDMAP
4.3.5. Almas Industries
4.3.6. Cardia International (Skanray Healthcare)
4.3.7. Nihon Kohden
4.3.8. Philips Healthcare
4.3.9. Physio-Control (Stryker)
4.3.10. Pyrescom
4.3.11. Schiller
4.3.12. Spacelabs Healthcare
4.3.13. Zoll

5. Market analysis and forecasts
5.1. Market forecasts
5.1.1. Cardiac rhythm management
5.1.2. Sleep therapy
5.1.3. Telehealth and multiparameter monitoring
5.1.4. ECG monitoring
5.1.5. Glucose level monitoring
5.1.6. Medication compliance monitoring
5.1.7. Other medical devices
5.2. Revenue forecasts
5.2.1. Medical monitoring devices
5.2.2. mHealth connectivity solutions
5.2.3. Care delivery platforms
5.2.4. mHealth care programs
5.3. Industry trends and analysis
5.3.1. Connectivity strong trend when new players enter the market
5.3.2. Major pharmaceutical companies prepare large-scale rollouts
5.3.3. Consumerisation of medical-grade mHealth devices and apps
5.3.4. BYOD is becoming a popular and viable option
5.3.5. Digitalisation of PSTN networks in the works
5.3.6. Modularization of the value chain as the market matures
5.3.7. Automated external defibrillators are getting connected
5.3.8. The data war has started
5.4. Market drivers and barriers
5.4.1. An ageing population is raising medical costs
5.4.2. Obesity epidemic and Increasing welfare disease prevalence
5.4.3. Increased focus on disease prevention
5.4.4. Substitutes to medical monitoring
5.4.5. A slowly changing industry
5.4.6. Alignment of financial incentives
5.5. Potential market catalysts
5.5.1. Increased monitoring during clinical trials
5.5.2. Incentives from insurance companies and payers
5.5.3. National health systems support remote monitoring
5.5.4. New clinical evidence on cost effectiveness
5.5.5. Non-prescribed monitoring and healthcare consumerism

For more information about this report visit https://www.researchandmarkets.com/research/282357/mhealth_and_home

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: E-Healthcare, Home Testing and Home Healthcare

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.